Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States
- 22 April 2010
- Vol. 51 (5), 838-844
- https://doi.org/10.1111/j.1528-1167.2009.02422.x
Abstract
Compare annual direct and indirect costs between privately insured U.S. patients with epileptic partial onset seizures (POS) and matched controls. One thousand eight hundred fifty-nine patients (including a subset of 758 employees) with >or=1 (POS) diagnosis (ICD-9-CM: 345.4.x-345.7.x), 1999-2004, ages 16-64 years, were identified from a privately insured claims database. Control group was an age- and gender-matched cohort of randomly chosen beneficiaries without epilepsy (ICD-9-CM: 345.x). All were required to have continuous health coverage during 2004 (baseline) and 2005 (study period). Chi-square tests were used to compare baseline comorbidities. Univariate and multivariate analyses were used for comparisons of annual direct (medical and pharmaceutical) and indirect costs during the study period. Patients with POS were on average 42 years of age, and 57% were women. Patients with POS had significantly higher rates of mental health disorders, migraine, and other neurologic disorders, and higher Charlson comorbidity index (CCI) compared with controls. On average, direct annual costs were significantly higher for POS patients ($11,276) compared with controls ($4,087), p < 0.001; difference of $7,190. Epilepsy-related costs (i.e., costs for antiepileptic drugs, claims with epilepsy or convulsions diagnoses) accounted for $3,290 (29% of direct costs). Employees with POS had substantial and significantly higher indirect (disability- and medically related absenteeism) costs compared with controls ($3,431 vs. $1,511, p < 0.001). Multivariate analyses supported the matched-control univariate findings. Patients with POS had significantly higher costs compared with matched controls. Epilepsy-related costs underestimate the excess costs of patients with partial onset seizures.This publication has 15 references indexed in Scilit:
- The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the USPharmacoEconomics, 2009
- PND15 THE INDIRECT COST BURDEN OF EPILEPSY IN THE UNITED STATESValue in Health, 2008
- PND11 EPILEPSY COST OF ILLNESS IN THE U.S. PRIVATELY INSUREDValue in Health, 2008
- Direct and indirect costs among employees with diabetic retinopathy in the United StatesCurrent Medical Research and Opinion, 2008
- Refractory Epilepsy: Clinical OverviewEpilepsia, 2007
- Cost of Illness of Epilepsy in the US: Comparison of Patient-Based and Population-Based EstimatesNeuroepidemiology, 2000
- Early Identification of Refractory EpilepsyThe New England Journal of Medicine, 2000
- Cost of Epilepsy in the United States: A Model Based on Incidence and PrognosisEpilepsia, 1994
- Intractable Partial Epilepsy: Evaluation and TreatmentMayo Clinic Proceedings, 1990
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987